Bial bails after Parkinson’s fail, axing asset over phase 2 miss Read more →
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer Read more →
City aims to lay foundation for RNAi renaissance with nearly $100M series B Read more →